OA11972A - Substituted phenoxyacetic acids. - Google Patents
Substituted phenoxyacetic acids. Download PDFInfo
- Publication number
- OA11972A OA11972A OA1200100338A OA1200100338A OA11972A OA 11972 A OA11972 A OA 11972A OA 1200100338 A OA1200100338 A OA 1200100338A OA 1200100338 A OA1200100338 A OA 1200100338A OA 11972 A OA11972 A OA 11972A
- Authority
- OA
- OAPI
- Prior art keywords
- fluoro
- phenoxy
- acetic acid
- benzylcarbamoyl
- bromo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14106899P | 1999-06-25 | 1999-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA11972A true OA11972A (en) | 2006-04-18 |
Family
ID=22494031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200100338A OA11972A (en) | 1999-06-25 | 2000-06-23 | Substituted phenoxyacetic acids. |
Country Status (24)
Country | Link |
---|---|
US (4) | US6420426B1 (fr) |
EP (1) | EP1198451A2 (fr) |
JP (1) | JP2003503381A (fr) |
KR (1) | KR20020013936A (fr) |
CN (1) | CN1364153A (fr) |
AP (1) | AP2001002377A0 (fr) |
AU (1) | AU5886900A (fr) |
BG (1) | BG106351A (fr) |
BR (1) | BR0011928A (fr) |
CA (1) | CA2385798A1 (fr) |
CZ (1) | CZ20014637A3 (fr) |
EE (1) | EE200100708A (fr) |
HU (1) | HUP0202384A3 (fr) |
IL (1) | IL147197A0 (fr) |
MX (1) | MXPA02003123A (fr) |
NO (1) | NO20016272L (fr) |
NZ (1) | NZ516290A (fr) |
OA (1) | OA11972A (fr) |
PL (1) | PL355857A1 (fr) |
SK (1) | SK19152001A3 (fr) |
TN (1) | TNSN00139A1 (fr) |
TR (1) | TR200200619T2 (fr) |
WO (1) | WO2001000566A2 (fr) |
ZA (1) | ZA200200300B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0202384A3 (en) * | 1999-06-25 | 2003-03-28 | Inst For Pharm Discovery Inc | Substituted phenoxyacetic acids |
US6768008B2 (en) * | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US6958355B2 (en) | 2000-04-24 | 2005-10-25 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
KR100356374B1 (ko) * | 2000-09-14 | 2002-10-19 | 사회복지법인삼성생명공익재단(삼성서울병원) | 안지오텐신 전환효소 억제제의 부작용으로 발생하는마른기침을 저해하기 위한 철분을 포함하는 기침 저해조성물 |
AU2001294673A1 (en) | 2000-09-21 | 2002-04-02 | Aryx Therapeutics | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis |
JP2005502600A (ja) * | 2001-06-07 | 2005-01-27 | イーライ・リリー・アンド・カンパニー | ペルオキシソーム増殖因子活性化受容体(ppar)のモジュレーター |
DE602004010889T2 (de) | 2003-02-14 | 2008-12-11 | Eli Lilly And Co., Indianapolis | Sulfonamid-derivate als ppar-modulatoren |
EP1620420A2 (fr) * | 2003-04-30 | 2006-02-01 | The Institutes for Pharmaceutical Discovery, LLC | Acides carboxyliques substitues |
DE602005025755D1 (de) | 2004-06-04 | 2011-02-17 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
EP1805136A1 (fr) * | 2004-10-28 | 2007-07-11 | The Institutes for Pharmaceutical Discovery, LLC | Acies phenylalcanoiques substitues |
GB0427603D0 (en) * | 2004-12-16 | 2005-01-19 | Novartis Ag | Organic compounds |
US10640457B2 (en) | 2009-12-10 | 2020-05-05 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and uses thereof |
ES2820863T3 (es) * | 2010-12-22 | 2021-04-22 | Univ Columbia | Moduladores de histona acetiltransferasa y usos de los mismos |
WO2018002673A1 (fr) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii |
CN109289696B (zh) * | 2018-10-29 | 2022-03-22 | 天津先光化工有限公司 | 一种咪唑啉两性表面活性剂的制备方法 |
CN114790133B (zh) * | 2021-01-26 | 2024-06-18 | 江苏中旗科技股份有限公司 | 一种以2-氯-4-氨基苯腈为原料合成2-氯-4-氟苯甲酸的方法 |
CN114790139B (zh) * | 2021-01-26 | 2024-06-18 | 江苏中旗科技股份有限公司 | 一种以2-氯-4-氨基溴苯为原料合成2-氯-4-氟苯甲酸的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994479A (en) * | 1985-04-03 | 1991-02-19 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylene derivatives and anti-allergic use thereof |
JPH04297466A (ja) * | 1990-06-22 | 1992-10-21 | Nippon Shinyaku Co Ltd | テトラゾール誘導体及び医薬 |
WO1994008945A1 (fr) | 1992-10-16 | 1994-04-28 | Byk Nederland Bv | Esters d'ethanolamine substitues |
GB9511694D0 (en) * | 1995-06-09 | 1995-08-02 | Fujisawa Pharmaceutical Co | Benzamide derivatives |
HUP0202384A3 (en) * | 1999-06-25 | 2003-03-28 | Inst For Pharm Discovery Inc | Substituted phenoxyacetic acids |
-
2000
- 2000-06-23 HU HU0202384A patent/HUP0202384A3/hu unknown
- 2000-06-23 SK SK1915-2001A patent/SK19152001A3/sk unknown
- 2000-06-23 US US09/603,817 patent/US6420426B1/en not_active Expired - Fee Related
- 2000-06-23 AU AU58869/00A patent/AU5886900A/en not_active Abandoned
- 2000-06-23 AP APAP/P/2001/002377A patent/AP2001002377A0/en unknown
- 2000-06-23 JP JP2001506979A patent/JP2003503381A/ja active Pending
- 2000-06-23 NZ NZ516290A patent/NZ516290A/xx unknown
- 2000-06-23 OA OA1200100338A patent/OA11972A/en unknown
- 2000-06-23 BR BR0011928-8A patent/BR0011928A/pt not_active IP Right Cessation
- 2000-06-23 WO PCT/US2000/017377 patent/WO2001000566A2/fr not_active Application Discontinuation
- 2000-06-23 CA CA002385798A patent/CA2385798A1/fr not_active Abandoned
- 2000-06-23 PL PL00355857A patent/PL355857A1/xx not_active Application Discontinuation
- 2000-06-23 MX MXPA02003123A patent/MXPA02003123A/es unknown
- 2000-06-23 TN TNTNSN00139A patent/TNSN00139A1/fr unknown
- 2000-06-23 IL IL14719700A patent/IL147197A0/xx unknown
- 2000-06-23 CN CN00809446A patent/CN1364153A/zh active Pending
- 2000-06-23 TR TR2002/00619T patent/TR200200619T2/xx unknown
- 2000-06-23 EE EEP200100708A patent/EE200100708A/xx unknown
- 2000-06-23 CZ CZ20014637A patent/CZ20014637A3/cs unknown
- 2000-06-23 EP EP00944834A patent/EP1198451A2/fr not_active Withdrawn
- 2000-06-23 KR KR1020017016636A patent/KR20020013936A/ko not_active Application Discontinuation
-
2001
- 2001-12-20 NO NO20016272A patent/NO20016272L/no not_active Application Discontinuation
-
2002
- 2002-01-14 ZA ZA200200300A patent/ZA200200300B/xx unknown
- 2002-01-25 BG BG06351A patent/BG106351A/bg unknown
- 2002-07-16 US US10/195,964 patent/US20030036558A1/en not_active Abandoned
-
2003
- 2003-09-12 US US10/662,135 patent/US7189749B2/en not_active Expired - Fee Related
-
2007
- 2007-03-13 US US11/685,336 patent/US20070161631A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070161631A1 (en) | 2007-07-12 |
ZA200200300B (en) | 2003-08-27 |
NO20016272D0 (no) | 2001-12-20 |
EP1198451A2 (fr) | 2002-04-24 |
BR0011928A (pt) | 2002-04-09 |
US7189749B2 (en) | 2007-03-13 |
TR200200619T2 (tr) | 2003-01-21 |
BG106351A (bg) | 2002-09-30 |
NZ516290A (en) | 2004-03-26 |
TNSN00139A1 (fr) | 2005-11-10 |
US20030036558A1 (en) | 2003-02-20 |
NO20016272L (no) | 2002-01-17 |
EE200100708A (et) | 2003-02-17 |
SK19152001A3 (sk) | 2002-06-04 |
CZ20014637A3 (cs) | 2002-04-17 |
IL147197A0 (en) | 2002-08-14 |
WO2001000566A2 (fr) | 2001-01-04 |
CA2385798A1 (fr) | 2001-01-04 |
KR20020013936A (ko) | 2002-02-21 |
MXPA02003123A (es) | 2003-08-20 |
WO2001000566A3 (fr) | 2002-02-07 |
AU5886900A (en) | 2001-01-31 |
US6420426B1 (en) | 2002-07-16 |
HUP0202384A2 (hu) | 2002-11-28 |
JP2003503381A (ja) | 2003-01-28 |
HUP0202384A3 (en) | 2003-03-28 |
CN1364153A (zh) | 2002-08-14 |
AP2001002377A0 (en) | 2001-12-31 |
PL355857A1 (en) | 2004-05-31 |
US20050239849A1 (en) | 2005-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070161631A1 (en) | Substituted Phenoxyacetic Acids | |
US7772237B2 (en) | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives | |
RU2193556C2 (ru) | Циклические тиозамещенные производные амида ациламинокислоты и способ их получения | |
US20090176837A1 (en) | Compounds with activity at retinoic acid receptors | |
WO2006088705A1 (fr) | Guanidine de terphenyle en tant qu'inhibiteurs de la $g(b)-secretase | |
HU211138A9 (en) | Therapeutic amides | |
JP4859828B2 (ja) | チオ−置換ビアリールメタンスルティニル誘導体 | |
US20020177594A1 (en) | Inhibitors of histone deacetylase | |
CA2523714A1 (fr) | Acides carboxyliques substitues | |
CA2984974C (fr) | Derives d'indenoindole, sels pharmaceutiquement acceptables ou isomeres optiques de ceux-ci, leur procede de preparation et compositions pharmaceutiques les contenant en tant que principe actif pour la prevention ou le traitement de maladies virales | |
CN109053630B (zh) | 一种苯并噻唑类衍生物及其用途 | |
CA2499213A1 (fr) | Modulateurs des recepteurs hepatiques x aromatiques | |
FI96951C (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen sulfonamidien ja läheisten yhdisteiden valmistamiseksi | |
EP0398179A1 (fr) | Dérivés de rhodanine et composés pharmaceutiques | |
JP2006511564A (ja) | 抗炎症剤、免疫調節剤及び増殖抑制剤としてシクロアルケンジカルボン酸化合物 | |
US8071604B2 (en) | Thio-substituted arylmethanesulfinyl derivatives | |
KR100223231B1 (ko) | 아닐린 및 벤질아민으로부터 얻어진 벤질셀레노벤즈아미드 및 그 제조 방법 | |
JP3086519B2 (ja) | チアゾリン誘導体 | |
KR20120035684A (ko) | IKK-β 억제제로서 신규 티아졸리디논 화합물 및 그의 제조방법 | |
EP1589016A1 (fr) | Dérivés tricycliques et bicycliques aromatiques de méthansulfinyle, substitués par THIO |